Intrexon Corporation (NYSE: XON) announced today that it has priced its previously announced underwritten public offering of common stock consisting of 6,000,000 shares at a public offering price of $12.50 per share. In addition, Intrexon has granted the underwriters a 30-day option to purchase up to an additional 900,000 shares of common stock offered in the public offering.

The offering is expected to close on January 19, 2018, subject to customary closing conditions. Gross proceeds to Intrexon from the offering are expected to be approximately $75 million before deducting the underwriting discount and other offering expenses payable by Intrexon and excluding any exercise of the underwriters' option.

JMP Securities LLC is acting as sole book-running manager and Stifel is acting as lead manager for the offering. Northland Capital Markets is acting as co-manager.

About Intrexon Corporation

Intrexon Corporation (NYSE: XON) is Powering the Bioindustrial Revolution with Better DNA™ to create biologically-based products that improve the quality of life and the health of the planet. Intrexon's integrated technology suite provides its partners across diverse markets with industrial-scale design and development of complex biological systems delivering unprecedented control, quality, function, and performance of living cells.